RE:RE:Bring in the cavalryOne of the main reasons that clinical trials take a tremendous amount of time (3.5 years) is that the quality of drug is increased as the drug moves from Phase I-Phase II-Phase III (10.5 years). This process can take up to 9 months in preparation for the next trial. Often retail does not understand this as the process is not common as with 85% phase II failure rate. Comparing the normal process of issuing phase II results and then preparing for a phase III trial while raising funds from the market... BLU , SAVA, TRIL. ARCH Management looks like they were being proactive, as stated in the recent news release.
The Company’s responsibilities during the trial include supplying LSALT drug vials to support the trial until completion. Arch completed the manufacturing of a new supply of vials during the summer and autumn of this year and has enough drug supply on hand for the 320 patients scheduled to be dosed in the CATCO trial.
So now the company has the drug (Metablok/LSALT Peptide) in hand and the Government is funding the trial. This opportunity is extremely rare in this sector and the street doesnt seem to understand it yet. Statistically we now have a 52.8% chance of bringing Metablok to market.